Drug Shortage Report for SANDOZ IRBESARTAN HCT

Last updated on 2023-10-02 History
Report ID 204738
Drug Identification Number 02337444
Brand name SANDOZ IRBESARTAN HCT
Common or Proper name IRBESARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500FCT
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-09-19
Estimated end date 2023-12-15
Actual end date
Shortage status Actual shortage
Updated date 2023-10-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-10-02 French Compare
v6 2023-10-02 English Compare
v5 2023-10-02 French Compare
v4 2023-10-02 English Compare
v3 2023-09-20 English Compare
v2 2023-09-19 French Compare
v1 2023-09-19 English Compare

Showing 1 to 7 of 7